Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880.

Dawne Gee welcomes The Flavor Queen to the WAVE Country studio to demonstrate her Classic American Potato Salad and preview her Cooking at the Cottage Series. WAVE Country. Waterfront Park Celebrates ...

The heat wave continues for much of the workweek with highs in the mid-90s and heat index values up to 105 degrees each afternoon. While isolated pop-up storms can’t be ruled out each day, better ...